Patient-reported outcomes in individuals with hepatitis C virus infection treated with elbasvir/graz...
Patient-reported outcomes in individuals with hepatitis C virus infection treated with elbasvir/grazoprevir
About this item
Full title
Author / Creator
Publisher
New Zealand: Dove Medical Press Limited
Journal title
Language
English
Formats
Publication information
Publisher
New Zealand: Dove Medical Press Limited
Subjects
More information
Scope and Contents
Contents
People chronically infected with hepatitis C virus (HCV) have diminished patient-reported outcomes (PROs). This study aimed to compare the impact of elbasvir/grazoprevir (EBR/GZR) treatment versus sofosbuvir with pegylated interferon and ribavirin (SOF/PR) on changes in PROs: 1) during the treatment period and 2) at posttreatment follow-up.
PRO...
Alternative Titles
Full title
Patient-reported outcomes in individuals with hepatitis C virus infection treated with elbasvir/grazoprevir
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_0ab1aa25aa7549f69aa4a24ad270b8a5
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_0ab1aa25aa7549f69aa4a24ad270b8a5
Other Identifiers
ISSN
1177-889X
E-ISSN
1177-889X
DOI
10.2147/PPA.S172732
